000			01905 a2200481 4500
005			20250515152804.0
264		0	_c20090626
008			200906s 0 0 spa d
022			_a0213-005X
024	7		_a10.1016/s0213-005x(08)76518-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aCalleja, José Luis
245	0	0	_a[Entecavir]. _h[electronic resource]
260			_bEnfermedades infecciosas y microbiologia clinica _cMay 2008
300			_a39-48 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAdenine _xadministration & dosage
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aClinical Trials as Topic _xstatistics & numerical data
650	0	4	_aDrug Resistance, Viral
650	0	4	_aDrug Therapy, Combination
650	0	4	_aGenotype
650	0	4	_aGuanine _xadministration & dosage
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHepatitis B e Antigens _xanalysis
650	0	4	_aHepatitis B virus _xdrug effects
650	0	4	_aHepatitis B, Chronic _xcomplications
650	0	4	_aHumans
650	0	4	_aLamivudine _xadministration & dosage
650	0	4	_aLiver Cirrhosis _xdrug therapy
650	0	4	_aLiver Transplantation
650	0	4	_aMulticenter Studies as Topic _xstatistics & numerical data
650	0	4	_aOrganophosphonates _xadministration & dosage
650	0	4	_aRandomized Controlled Trials as Topic _xstatistics & numerical data
650	0	4	_aReverse Transcriptase Inhibitors _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
650	0	4	_aVirus Replication _xdrug effects
700	1		_aPeñas, Beatriz
773	0		_tEnfermedades infecciosas y microbiologia clinica _gvol. 26 Suppl 7 _gp. 39-48
856	4	0	_uhttps://doi.org/10.1016/s0213-005x(08)76518-2 _zAvailable from publisher's website
999			_c18551091 _d18551091